Clinical Characteristics, Comorbidity Profile, and Medication Use Among Patients with Heart Failure: A Cross-Sectional Study

Background: Heart failure (HF) is associated with substantial morbidity and frequently occurs alongside multiple comorbidities, contributing to complex medication use. This study aimed to describe the clinical characteristics, comorbidities, laboratory findings, and medication use among patients with HF in Saudi Arabia, focusing on sex differences. Methods: A retrospective cross-sectional study was conducted among adults with heart failure at King Abdul-Aziz Medical City, Saudi Arabia. Data from electronic medical records (2016–2018) were analyzed for demographic, clinical, laboratory, comorbidity, and medication characteristics. Differences between male and female patients were assessed using appropriate statistical tests, with odds ratios and 95% confidence intervals calculated for selected variables. Statistical significance was set at p < 0.05. Results: Among 1363 patients, 669 (49.1%) were male and 694 (50.9%) female. Females had higher BMI (34.64 ± 7.99 vs. 28.99 ± 6.91 kg/m2, p < 0.001), hypertension (50.7% vs. 41.4%; p < 0.001), diabetes (47.4% vs. 40.7%; p = 0.012), and atrial fibrillation (29.7% vs. 20.0%; p < 0.001). Males had higher smoking prevalence (60.4% vs. 3.3%; p < 0.001), ischaemic heart disease (43.6% vs. 27.1%; OR 2.08, 95% CI 1.66–2.61; p < 0.001), creatinine (p < 0.001), and BNP (p = 0.004). Beta-blocker and ACE inhibitor use was higher among males, whereas ARB use was higher among females (all p < 0.05). Conclusions: In this study, patients with heart failure had a high burden of cardiovascular and cardiometabolic comorbidities, with notable sex-related differences in clinical characteristics, comorbidities, laboratory measures, and medication use. These findings provide real-world evidence on HF profiles and medication use in a Saudi tertiary-care setting and highlight the need for multicenter studies to characterize these patterns across diverse populations.

Authors

Institutions

Publication Details

Journal
Life
Published
2026-11-13
DOI
https://doi.org/10.3390/life16111921
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical Characteristics, Comorbidity Profile, and Medication Use Among Patients with Heart Failure: A Cross-Sectional Study

Ada Alqunaibet, Sitah Alharthi, Asma M. Alshahrani, Geetha Kandasamy et al.
1 links
Life
Heart Failure Treatment and Management
article

Clinical Characteristics, Comorbidity Profile, and Medication Use Among Patients with Heart Failure: A Cross-Sectional Study

Ada Alqunaibet, Sitah Alharthi, Asma M. Alshahrani, Geetha Kandasamy, Abdullah S. Alshammari, Sarah Mohammed Alyousif, Sami Alsalmi
article en

Abstract

Background: Heart failure (HF) is associated with substantial morbidity and frequently occurs alongside multiple comorbidities, contributing to complex medication use. This study aimed to describe the clinical characteristics, comorbidities, laboratory findings, and medication use among patients with HF in Saudi Arabia, focusing on sex differences. Methods: A retrospective cross-sectional study was conducted among adults with heart failure at King Abdul-Aziz Medical City, Saudi Arabia. Data from electronic medical records (2016–2018) were analyzed for demographic, clinical, laboratory, comorbidity, and medication characteristics. Differences between male and female patients were assessed using appropriate statistical tests, with odds ratios and 95% confidence intervals calculated for selected variables. Statistical significance was set at p < 0.05. Results: Among 1363 patients, 669 (49.1%) were male and 694 (50.9%) female. Females had higher BMI (34.64 ± 7.99 vs. 28.99 ± 6.91 kg/m2, p < 0.001), hypertension (50.7% vs. 41.4%; p < 0.001), diabetes (47.4% vs. 40.7%; p = 0.012), and atrial fibrillation (29.7% vs. 20.0%; p < 0.001). Males had higher smoking prevalence (60.4% vs. 3.3%; p < 0.001), ischaemic heart disease (43.6% vs. 27.1%; OR 2.08, 95% CI 1.66–2.61; p < 0.001), creatinine (p < 0.001), and BNP (p = 0.004). Beta-blocker and ACE inhibitor use was higher among males, whereas ARB use was higher among females (all p < 0.05). Conclusions: In this study, patients with heart failure had a high burden of cardiovascular and cardiometabolic comorbidities, with notable sex-related differences in clinical characteristics, comorbidities, laboratory measures, and medication use. These findings provide real-world evidence on HF profiles and medication use in a Saudi tertiary-care setting and highlight the need for multicenter studies to characterize these patterns across diverse populations.

LifeVol. 16(11)
King Saud bin Abdulaziz University for Health Sciences (SA), Umm al-Qura University (SA), Shaqra University (SA), King Abdullah International Medical Research Center (SA), National Guard Health Affairs (SA), King Khalid University (SA)
King Khalid University
Good health and well-being
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon